My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viemed Healthcare, Inc. - Common Shares (NQ:VMD)

6.620 -0.160 (-2.36%)
Streaming Delayed Price Updated: 3:28 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viemed Healthcare, Inc. - Common Shares

< Previous 1 2 3 Next >
Viemed Healthcare Announces Completion of Share Repurchase Program
Via ACCESS Newswire
Viemed VMD Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Viemed (VMD) Q2 Revenue Rises 15%
Via The Motley Fool
Viemed Healthcare Announces Second Quarter 2025 Financial Results
Via ACCESS Newswire
Earnings Scheduled For August 6, 2025
 
Via Benzinga
Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details
Via ACCESS Newswire
Earnings Scheduled For May 7, 2025
 
Via Benzinga
Viemed Healthcare's Earnings Outlook
 
Via Benzinga
Viemed Healthcare Earnings Preview
 
Via Benzinga
Earnings Preview For Viemed Healthcare
 
Via Benzinga
Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results
Via ACCESS Newswire
Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Earnings Scheduled For March 10, 2025
 
Via Benzinga
Viemed Healthcare Inc. (NASDAQ: VMD) is a Stock Spotlight on 4/11
Via Investor Brand Network
JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Ingles Markets, Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Super Micro Computer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
VMD Stock Earnings: Viemed Healthcare Misses EPS, Misses Revenue for Q2 2024
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
VMD Stock Earnings: Viemed Healthcare Misses EPS, Beats Revenue for Q1 2024
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Viemed Healthcare's Earnings Outlook
 
Via Benzinga
VMD Stock Earnings: Viemed Healthcare Misses EPS, Beats Revenue for Q4 2023
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
3 Undervalued Small-Cap Stocks for Your Labor Day Watchlist
Here are three small-cap stocks that may be ready to make large moves once volume increases in the markets after Labor Day 
Via MarketBeat
The 7 Most Undervalued Stocks Under $10 to Buy Now: August 2023
While consumer prices may be hot, these stocks undervalued stocks to buy under $10 proves you can still catch a bargain. 
Via InvestorPlace
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million. 
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. 
Via Benzinga
Earnings Scheduled For March 2, 2023
Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million. 
Via Benzinga
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
7 Best Stocks to Buy Under $7
If you only have a few bucks to spare for investing, these are the best stocks to buy under $7 that bargain hunters should target. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.